← Back to Search

Opioid Analgesic

Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis (OCKD Trial)

Phase 4
Waitlist Available
Led By Oscar A Linares, MD
Research Sponsored by Emerio & Lourdes Linares Research and Education Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Pivotal Trial
Drug Has Already Been Approved
All Individual Drugs Already Approved
Approved for 10 Other Conditions
No Placebo-Only Group

Summary

To measure oxycodone's intradialytic mass transfer rate coefficient and oxycodone's removal rate using an ODE/PDE hemodialysis model. To implement a rational clinical strategy for estimating a patient's post-hemodialysis oxycodone restoration dose using results from an ODE/PDE model of hemodialysis.

Eligible Conditions
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: hemodialysisExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Group II: controlExperimental Treatment1 Intervention
Oxycodone will be administered and subjects will undergo hemodialysis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxycodone
FDA approved

Find a Location

Who is running the clinical trial?

Emerio & Lourdes Linares Research and Education CenterLead Sponsor
Oscar A Linares, MDPrincipal InvestigatorEmerio & Lourdes Linares Research and Education Center
~2 spots leftby Jan 2026